1-13 of 13
mutation accumulation
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Prognostic Impact of Clonal Diversity in Acute Myeloid Leukemia (AML) Treated with Intensive Chemotherapy (IC)

Marco Cerrano, MD, Marie Passet, PharmD, Loic Vasseur, MD, Pierre Hirsch, MD PhD, Xavier Thomas, MD PhD, Samuel Quentin, Justine Pasanisi, Florence Rabian, MD, Ramy Rahmé, MD, Etienne Lengline, MD, Emmanuel Raffoux, MD, Nathalie Dhedin, MD, Marie Sebert, MD, Odile Maarek, Anna Raimbault, PhD, Karine Celli-Lebras, CRA, Lionel Ades, MD PhD, Pierre Fenaux, MD PhD, Nicolas Boissel, MD PhD, Francois Delhommeau, MD PhD, Jean Soulier, MD PhD, Herve Dombret, MD PhD, Emmanuelle Clappier, PhD PharmD, Pierre Sujobert, MD PhD, Raphael Itzykson, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2700.
https://doi.org/10.1182/blood-2019-127475
Published: 2019
Journal Articles

Comprehensive Genomic Analysis of IDH Inhibitor-Treated AML Samples Delineates Molecular Mechanisms of Differentiation and Heterogeneous Patterns of Acquired Resistance

Feng Wang, PhD, Kiyomi Morita, MD, Courtney D. DiNardo, MDMSc, Keyur Patel, MD PhD, Kyle MacBeth, PhD, Alessandra Tosolini, BS, Mark G. Frattini, MD, Jairo Matthews, BA, Latasha Little, Curtis Gumbs, Samantha Tippen, Xingzhi Song, PhD, Jianhua Zhang, PhD, Erika Thompson, MS, Tapan M. Kadia, MD, Guillermo Garcia-Manero, MD, Elias J. Jabbour, MD, Farhad Ravandi, MD, Marina Y. Konopleva, MD PhD, Hagop M. Kantarjian, MD, Andrew Futreal, PhD, Koichi Takahashi, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 441.
https://doi.org/10.1182/blood-2018-99-116383
Published: 2018
Journal Articles

Progression to AML Is Predictable and Distinct from Age Related Clonal Hematopoiesis

Sagi Abelson, PhD, Stanley W.K. Ng, Omer Wiessbrod, Philip Zuzarte, Lawrence Heisler, Yogi Sundaravadanam, Ting Ting Wang, Trevor J. Pugh, PhD, David Soave, Paul Brennan, Mattias Johansson, Phillip Awadalla, Scott V. Bratman, Jean Wang, MD PhD, Mark D. Minden, MD PhD, John E. Dick, PhD, Liran I. Shlush
Journal: Blood
Blood (2017) 130 (Supplement 1): 471.
https://doi.org/10.1182/blood.V130.Suppl_1.471.471
Published: 2017
Journal Articles

Clonal Hematopoiesis in Normal Individuals Is Not Random and Likely Reflects Early MDS

Wanlong Ma, MS, Ivan De Dios, BS, Vincent Funari, PhD, Sucha Sudarsanam, MS, Shi-Ping Jiang, MD, Sally Agersborg, MD PhD, Jennifer Hummel, MD MPH, Forrest Blocker, PhD, Maher Albitar, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4269.
https://doi.org/10.1182/blood.V130.Suppl_1.4269.4269
Published: 2017
Journal Articles

Altered Expression of the Repair Genes in CD34+ Cells May be Responsible for Formation and Accumulation of Mutations in MDS Patients

Jan Valka, MD, Monika Belickova, Jitka Vesela, Eliska Stara, Barbora Pejsova, Anna Jonasova, MD PhD
Journal: Blood
Blood (2015) 126 (23): 4119.
https://doi.org/10.1182/blood.V126.23.4119.4119
Published: 2015
Journal Articles

p53 Co-Activator Aspp1 Induces Apoptosis in Damaged Hematopoietic Stem Cells and Prevents Malignant Transformation

Masayuki Yamashita, MD PhD, Eriko Nitta, MD PhD, Toshio Suda, MD PhD
Journal: Blood
Blood (2014) 124 (21): 603.
https://doi.org/10.1182/blood.V124.21.603.603
Published: 2014
Journal Articles

Identifying Novel Genes and Signaling Pathways That Predispose to Therapy Related MDS (t-MDS)

Shailaja Akunuru, PhD, Kimberly Seymore, Rupali Kumar, Kalpana Nattamai, Hartmut Geiger
Journal: Blood
Blood (2014) 124 (21): 1905.
https://doi.org/10.1182/blood.V124.21.1905.1905
Published: 2014
Journal Articles

Targeted Ultra-Deep High Accuracy Sequencing of Pre-Treatment AML Reveals a Diversity of Mutational Phenotypes and Evidence of Preexisting Relapse-Associated Subclones

Marc J. Prindle, PhD, Lawrence A. Loeb, MD PhD, Elihu H. Estey, MD, Pamela S. Becker, MD PhD
Journal: Blood
Blood (2014) 124 (21): 2372.
https://doi.org/10.1182/blood.V124.21.2372.2372
Published: 2014
Journal Articles

Identification Of Genes/Signaling Pathways That Predispose To Therapy Related MDS (t-MDS)

Shailaja Akunuru, PhD, Kimberly Seymore, Kalpana Nattamai, Yi Zheng, PhD, Hartmut Geiger
Journal: Blood
Blood (2013) 122 (21): 2817.
https://doi.org/10.1182/blood.V122.21.2817.2817
Published: 2013
Journal Articles

Exo1 Independent DNA Mismatch Repair Pathway in Hematopoiesis.

Amar Desai, Yulan Qing, PhD, Min Liu, Jonathan Kenyon, BS, Uchenna Nwafor, Stanton L. Gerson, MD
Journal: Blood
Blood (2009) 114 (22): 2526.
https://doi.org/10.1182/blood.V114.22.2526.2526
Published: 2009
Journal Articles

TET2 Mutations Are Not Specific for Certain MPN Entities but More Likely Seem to Indicate Disease Progression.

Susanne Schnittger, PhD, Claudia Tschulik, Nicole Wendland, Sonja Schindela, Frank Dicker, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Haferlach, MD
Journal: Blood
Blood (2009) 114 (22): 438.
https://doi.org/10.1182/blood.V114.22.438.438
Published: 2009
Journal Articles

Rearrangement and Deletion of the PAX5 Gene in Pediatric Acute B-Cell Lineage Lymphoblastic Leukemia.

Norihiko Kawamata, MD, Seishi Ogawa, M.D., Martin Zimmermann, Ph.D., Masashi Sanada, M.D., Kari Hemminki, M.D., Go Yamatomo, M.D., Yasuhito Nannya, M.D., Rolf Koehler, Ph.D., Thomas Flohr, Ph.D., Carl W. Miller, Ph.D., Jochen Harbott, M.D., Wolf-Dieter Ludwig, M.D., Martin Stanulla, M.D., Martin Schrappe, M.D., Claus R. Bartram, M.D., Phillip H. Koeffler, M.D.
Journal: Blood
Blood (2007) 110 (11): 981.
https://doi.org/10.1182/blood.V110.11.981.981
Published: 2007
Journal Articles

The nature of diversity and diversification at the ABO locus

Axel Seltsam, Michael Hallensleben, Anke Kollmann, Rainer Blasczyk
Journal: Blood
Blood (2003) 102 (8): 3035–3042.
https://doi.org/10.1182/blood-2003-03-0955
Published: 2003